News | Peripheral Artery Disease (PAD) | October 19, 2015

VIVA Physicians Announce Late-Breaking Clinical Trials for VIVA 15 Conference

Annual meeting for vascular medicine and intervention will include presentations on new devices and procedures, plus economic and clinical impacts

VIVA 15 conference, late-breaking clinical trials, VIVA Physicians

October 19, 2015 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the late-breaking sessions at its annual conference, VIVA 2015. Sixteen trial results, featuring the latest in vascular technology and devices, will be released for the first time Nov. 2-3 at the Wynn Las Vegas.

Presentations of the late-breaking trials (including the embargoed results) will be presented during the General Session and highlighted during press conferences.

Scheduled presentations cover numerous categories, including:

New Devices

  • Autogenous Arteriovenous Fistula Creation for Hemodialysis Access: Preliminary Results of the NEAT Trial
  • First-in-Man Study of the MobiusHD for the Treatment of Resistant Hypertension
  • Results of the VISION (combined imaging/atherectomy) Trial

New Procedures

  • Percutaneous Endovascular Bypass of Long SFA Occlusions: Interim Trial Results

Drug-eluting Stents and Drug Coated Balloons

  • MAJESTIC: DES 12-Month Performance Overall and in Diabetic Patients
  • Results from the IN.PACT Global Study
  • Results from the IN.PACT SFA IDE Trial
  • ILLUMENATE FIH: Two-year Results on the Stellarex DCB without Pre-dilatation
  • The Lutonix Global DCB Registry in Complex Femoro-popliteal Lesions
  • Zilver PTX Post-Market Surveillance Study in Japan: 24 Month Results

Aortic Aneurysm Repair

  • Least Invasive Fast-track EVAR: Midterm Results of the Multicenter LIFE registry
  • Endovascular Repair in Acute Type B Aortic Dissection: Two-year Results from the Valiant US-IDE Study
  • Four-Year Results Evaluating the Safety and Effectiveness of the Ovation System

Economic & Clinical Impact

  • DURABILITY Iliac & VISIBILITY Iliac Combined Clinical Trials
  • The SAPPHIRE Worldwide Study, the largest CAS experience ever presented
  • Economic Analysis of Endovascular Interventions to Treat Femoro-popliteal Artery Disease

For more information:

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init